Trade AbbVie ^ABBV

Canaccord Genuity Group Issues Positive Forecast for AbbVie (NYSE:ABBV) Stock Price

Bank of America Upgrades AbbVie (ABBV) on Skyrizi Strength, Lifts PT

AbbVie (NYSE:ABBV) Shares Up 3.8% Following Analyst Upgrade

AbbVie and adMare BioInnovations Announce RIME Therapeutics as AbbVie Biotech Innovators Award Recipient in Quebec | Taiwan News | May. 1, 2026 03:00

ABBV Maintained by Morgan Stanley -- Price Target Raised to $278

AbbVie (NYSE:ABBV) Price Target Raised to $278.00

Best Dividend Stocks To Follow Today - April 30th - Stock Observer

AbbVie's (ABBV) "Overweight" Rating Reaffirmed at Cantor Fitzgerald

Research Analysts' Price Target Changes for April 30th (ABBV, ACGL, AER, AMP, AMZN, ARE, AVY, BAND, BELFB, BILL) - Stock Observer

Stock Analysts' Updated EPS Estimates for April 30th (ABBV, AIRJ, AMT, AMZN, APPN, BTU, CMG, CMRC, CSTM, DCC) - Stock Observer

AbbVie (NYSE:ABBV) Issues Quarterly Earnings Results - Daily Political

AbbVie Inc. $ABBV Shares Sold by State of New Jersey Common Pension Fund D

US Bancorp DE Sells 41,982 Shares of AbbVie Inc. $ABBV

AbbVie Inc. (NYSE:ABBV) Q1 2026 Earnings Call Transcript

Deoxycholic Acid Obesity Drugs Market Analysis Report 2026: $970 Mn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

AbbVie Exceeds Earnings Expectations with Surge in Skyrizi and Rinvoq Sales Amid Humira Decline, ETPharma

OSE Immunotherapeutics Reports Full Year 2025 Unaudited Consolidated Financial Results and 2026 Q1 Cash Position | Taiwan News | Apr. 30, 2026 13:30

Q1 2026 AbbVie Inc Earnings Call Transcript

AbbVie Q1 Earnings Call Highlights

AbbVie's patent on immunology therapy rejected

AbbVie (ABBV) Reports Strong Q1 2026 Results and Raises Full-Year Guidance

AbbVie (NYSE:ABBV) Trading 3.3% Higher - Time to Buy?

AbbVie Inc (ABBV) Shares Surge 3.1% -- What GF Score of 85 Tells

AbbVie (NYSE:ABBV) Posts Earnings Results, Misses Expectations By $0.36 EPS

ABBV Misses Q2 Revenue Expectations Slightly

Keybank National Association OH Raises Stake in AbbVie Inc. $ABBV - Daily Political

AbbVie raises outlook as blockbuster Skyrizi faces new rivals

AbbVie Raises 2026 Outlook To $14.28 As Q1 Earnings Beat Estimates

ABBV Shows Strong Fundamentals and Progress in Programs

AbbVie (ABBV) Raises Full-Year Earnings Outlook Following Q1 Revenue Beat

Top Dividend Stocks To Research - April 29th - Daily Political

Is AbbVie (ABBV) 1.6% Undervalued After Q1 2026? Adjusted EPS $2.65 Beats vs. $1. ...

AbbVie (ABBV) Reports Q1 Results with Revenue Beat and EPS Miss

AbbVie (ABBV) Stock Jumps on Strong Q1 Beat and Upgraded Full-Year Forecast

AbbVie Q1 Profit Down, Revenues Rise; Lifts FY26 Earnings View - Update

AbbVie Q1 26 Earnings Conference Call At 9:00 AM ET

AbbVie tops quarterly expectations as newer immunology drugs offset Humira decline

Keybank National Association OH Boosts Holdings in AbbVie Inc. $ABBV

AbbVie Seeks FDA Approval To Expand RINVOQ Use For Alopecia Areata

Federal judge strikes down North Dakota pharmaceutical law as unconstitutional

AbbVie (ABBV) Anticipates Strong Q1 Earnings and Robust Growth Drivers

AbbVie (ABBV) Reports Superior Efficacy of Rinvoq Over Humira in

AbbVie Inc. $ABBV Shares Sold by Vest Financial LLC

RINVOQ® (upadacitinib) Demonstrated Superiority Versus HUMIRA® (adalimumab) for Primary Endpoint in a Head-to-Head Study in Rheumatoid Arthritis Patients Who Have Failed First TNF inhibitor

EvolveImmune Therapeutics Announces Achievement of Preclinical Milestone in Collaboration with AbbVie

AbbVie Inc. $ABBV Shares Sold by Arlington Trust Co LLC

KTF Investments LLC Makes New Investment in AbbVie Inc. $ABBV - Daily Political

AbbVie Inc. $ABBV Shares Sold by Mitsubishi UFJ Trust & Banking Corp - Daily Political

AbbVie (ABBV) Maintains Dividend Strength as Core Drugs Drive Cash Flow

AbbVie Seeks FDA Approval for Subcutaneous Skyrizi (ABBV)

Is Bristol Myers Squibb the Best Bargain in Big Pharma?

AbbVie Submits Regulatory Application to FDA for SKYRIZI® Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease | INN

Comerica Bank Trims Stock Position in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Bought by D.A. Davidson & CO.

Anchyra Partners LLC Buys Shares of 5,056 AbbVie Inc. $ABBV

Piper Sandler Cuts PT on AbbVie Inc. (ABBV) Ahead of Quarterly Results

AbbVie Inc. (ABBV) Receives CRL from the FDA About the Biologics License Application for trenibotulinumtoxinE

ABBVIE SP. Z O.O. secures contract for Pharmaceutical products

Therapeutic targeting of BCL-2 during CART cell production augments potency through non-apoptotic adaptive changes

AbbVie Inc. $ABBV Shares Acquired by Vanguard Group Inc.

Top Pharmaceutical Stocks To Keep An Eye On - April 26th - Daily Political

Sanctuary Advisors LLC Buys 6,911 Shares of AbbVie Inc. $ABBV

Axecap Investments LLC Increases Stock Position in AbbVie Inc. $ABBV

Abacus FCF Advisors LLC Decreases Position in AbbVie Inc. $ABBV

Vanguard Group Inc. Purchases 3,032,438 Shares of AbbVie Inc. $ABBV - Daily Political

Richard C. Young & CO. LTD. Acquires 6,966 Shares of AbbVie Inc. $ABBV - Daily Political

10 Dividend-Paying Stocks That Retirees Will Love to Have in Their Portfolios

AbbVie Faces FDA Rejection On Manufacturing Issues For Wrinkle Drug

Calamos Advisors LLC Grows Stock Holdings in AbbVie Inc. $ABBV

Mantle cell lymphoma outcomes following sequential first-line bendamustine-rituximab and second-line Bruton's tyrosine kinase inhibitor therapy

AbbVie's new Botox product TrenibotE stymied by FDA

AbbVie (NYSE:ABBV) Trading Down 2.3% - What's Next? - Daily Political

Procter & Gamble (PG) Reports Strong Earnings Ahead of Market Open

AbbVie Inc. $ABBV Shares Sold by Torray Investment Partners LLC

2,697 Shares in AbbVie Inc. $ABBV Bought by Wealth Science Advisors LLC - Stock Observer

Turtle Creek Wealth Advisors LLC Purchases 8,559 Shares of AbbVie Inc. $ABBV - Stock Observer

9,496 Shares in AbbVie Inc. $ABBV Purchased by Quent Long Short Global Small Cap Fund LP - Daily Political

Directional Asset Management Takes Position in AbbVie Inc. $ABBV - Daily Political

AbbVie's largest-ever capital investment of $1.4 B to build pharma manufacturing campus in US

AbbVie's US$1.4b AI-Powered Campus Reshapes Immunology And Neuroscience Story

FDA Requests Additional Information on AbbVie's Application for Neurotoxin | Morningstar

AbbVie (ABBV) Receives Complete Response Letter from FDA on Tren

Spotting Winners: AbbVie (NYSE:ABBV) And Therapeutics Stocks In Q4

These 5 Stocks Pay You Even When You're Sleeping

ABBV Maintains Overweight Rating - Price Target Lowered to $294

ABBV: Future Returns Will Rely On Immunology Expansion And Operating Leverage Execution

Pharmaceutical Stocks Worth Watching - April 23rd - Stock Observer

OLD National Bancorp IN Reduces Position in AbbVie Inc. $ABBV

Milestone Asset Management LLC Buys 19,094 Shares of AbbVie Inc. $ABBV - Markets Daily

Teacher Retirement System of Texas Has $134.75 Million Stock Position in AbbVie Inc. $ABBV - Markets Daily

AbbVie Inc. $ABBV Stake Boosted by Milestone Asset Management LLC - Stock Observer

AbbVie (ABBV): The Best Stock to Buy on a Pullback

AbbVie to invest $1.4bn in North Carolina manufacturing campus - The Manufacturer

Does AbbVie's Durham AI Plant and Ovarian Cancer Data Reframe the Bull Case for ABBV?

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

Week Ahead: Growth, Inflation, and Consumer Trends in Focus

Week Ahead: China Is On Holiday, But The BoC, The Fed, And The ECB Will Be Busy With The First 2025 Rate Announcements 

Week ahead: Magnificent 7 earnings, 2 key inflation reports

Week ahead: Earnings bonanza, ECB decision & US inflation

Week ahead: Fed, ECB & BoJ in action

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk